Ohshima T, Abe S, Tsutsui Y, Sakagawa T, Tarumoto Y, Nakane S, Sasajima M, Ohzeki M
J Toxicol Sci. 1981 Jul;6 Suppl:141-58. doi: 10.2131/jts.6.supplement_141.
The visual toxicity and the ototoxicity of hydrocortisone 17-butyrate 21-propionate (HBP), a newly synthesized anti-inflammatory steroid, was investigated using rats and dogs. (1) Electroretinogram (ERG) and visually evoked potential (VEP) in rats were not changed when HBP was administered intravenously and intraperitoneally, even at the semilethal doses. Consequently, it was suggested that HBP had no effect on the visual nervous system. (2) Similar to other corticosteroids, the intra ocular pressure rose in the dogs received HBP. Nevertheless, these dogs showed neither the remarkable changes in ERG, in the fundus of the eye, in the histological examination, nor the turbidity of the cornea and the lens. Based on these facts, it was reasonable to think that the the rise in the intra ocular pressure caused by HBP was not so severe that induce the secondary influence to other visual functions. (3) The rats received HBP did not show any changes in the auditory function by the audiometry. As the result, HBP was thought to be one of the rather safety corticosteroids concerning the visual toxicity and the ototoxicity.
使用大鼠和狗对新合成的抗炎甾体17 - 丁酸氢化可的松21 - 丙酸酯(HBP)的视觉毒性和耳毒性进行了研究。(1)即使以半致死剂量静脉内和腹膜内给予HBP,大鼠的视网膜电图(ERG)和视觉诱发电位(VEP)也没有变化。因此,提示HBP对视觉神经系统没有影响。(2)与其他皮质类固醇类似,接受HBP的狗眼压升高。然而,这些狗的ERG、眼底、组织学检查均未显示明显变化,角膜和晶状体也未出现混浊。基于这些事实,有理由认为HBP引起的眼压升高并不严重,不会对其他视觉功能产生继发性影响。(3)接受HBP的大鼠通过听力测定未显示听觉功能有任何变化。结果,HBP被认为是一种在视觉毒性和耳毒性方面相当安全的皮质类固醇。